Marshall Wace
BNR

Marshall Wace’s Burning Rock Biotech BNR Stock Holding History

Marshall Wace’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,903
Closed -$220K – 3211
2025
Q4 		$220K Buy
+10,903
New +$159K ﹤0.01% 2561
2022
Q4 		– Sell
-12,819
Closed -$305K – 2948
2022
Q3 		$305K Sell
12,819
-51,453
-80% -$1.66M ﹤0.01% 2944
2022
Q2 		$1.87M Buy
+64,272
New +$2.87M ﹤0.01% 2046
2022
Q1 		– Sell
-868
Closed -$83K – 3372
2021
Q4 		$83K Buy
+868
New +$119K ﹤0.01% 3428
2021
Q2 		– Sell
-5,177
Closed -$1.39M – 2669
2021
Q1 		$1.39M Sell
5,177
-19,149
-79% -$5.83M 0.01% 1498
2020
Q4 		$5.62M Buy
24,326
+20,631
+558% +$5.54M 0.03% 525
2020
Q3 		$927K Buy
+3,695
New +$876K 0.01% 1051

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CL
CRCM LP San Francisco, California $141M AUM 153.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RWMG
Redwood Wealth Management Group Medford, New Jersey $232M AUM 22.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

Marshall Wace's BNR Position: Q1 2026 in Review

Marshall Wace sold out of Burning Rock Biotech (BNR) in Q1 2026, closing a stake of 10,903 shares — an estimated $220K sold.

Marshall Wace first reported a position in BNR in Q3 2020 and held it in 7 quarters. The position peaked at $5.62M in Q4 2020. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

  • Marshall Wace reported no remaining Burning Rock Biotech position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 10,903 Burning Rock Biotech shares in Q1 2026, an estimated $220K.
  • Marshall Wace first reported a position in Burning Rock Biotech in Q3 2020 and held it in 7 quarters.
  • Marshall Wace's Burning Rock Biotech position peaked at $5.62M in Q4 2020.
  • 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.